Asia-Pacific

The $37bn investment arm of Denmark’s Novo Nordisk Foundation is building a roster of homegrown GPs in Asia and growing its regional headcount, says managing partner Amit Kakar.

In today's edition, A $66 billion LP says sector selection should be left to the experts; Greater China PE gets a shot in the arm; LPs are supporting their GPs on climate issues.

The pressing need for more healthcare professionals globally is proving a tailwind for PE investors in medical education.

The power of the global M&A market increasingly hinges on the presence of mega-deals.

In today's edition, LPs without VC allocations could be overexposed to the past, says LGT; KKR's Arctos capitalises on GP illiquidity; An IPO bonanza could spell good news for VC exits.

The private equity model isn’t broken, but the illusion of uniform success is, writes Scott Hart, partner and chief executive at StepStone Group.

Activity slowed in the first quarter as AI disruption, private credit pressures and geopolitical uncertainty weighed on the market, according to Bain & Company’s latest PE report.

The combination of the two firms, which will create the world's largest healthcare private equity investor, will change how healthcare investing is done by linking East and West opportunities, its co-chief executives tell PEI.

In the second instalment of PEI’s new podcast miniseries, we analyse the key findings from Secondaries Investor’s inaugural Global Market Survey.

In today's edition, A 'democratisation' expert says GPs will only get one chance to deliver; Blackstone reckons evergreen 'tests' are helpful for the industry; New Mountain wants to deepen its Korea ties.